Terms: = Kidney tumors AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Treatment
4 results:
1. Machine learning-based prediction model for late recurrence after surgery in patients with renal cell carcinoma.
Kim HM; Byun SS; Kim JK; Jeong CW; Kwak C; Hwang EC; Kang SH; Chung J; Kim YJ; Ha YS; Hong SH
BMC Med Inform Decis Mak; 2022 Sep; 22(1):241. PubMed ID: 36100881
[TBL] [Abstract] [Full Text] [Related]
2. Combined treatment of Tyrosine Kinase Inhibitor-Labeled Gold Nanorod Encapsulated Albumin With Laser Thermal Ablation in a Renal Cell Carcinoma Model.
Callaghan C; Peralta D; Liu J; Mandava SH; Maddox M; Dash S; Tarr MA; Lee BR
J Pharm Sci; 2016 Jan; 105(1):284-92. PubMed ID: 26852860
[TBL] [Abstract] [Full Text] [Related]
3. Resolution of Benign and Malignant Sebaceous Neoplasms, in a Renal Transplant Patient Treated With Everolimus.
Donati M; Paolino G; Muscardin L; Panetta C; Donati P
Exp Clin Transplant; 2017 Feb; 15(1):100-102. PubMed ID: 25924010
[TBL] [Abstract] [Full Text] [Related]
4. A phase II trial of intrapatient dose-escalated sorafenib in patients with metastatic renal cell carcinoma.
Amato R; Zhai J; Willis J; Saxena S; DeFoe M
Clin Genitourin Cancer; 2012 Sep; 10(3):153-8. PubMed ID: 22551785
[TBL] [Abstract] [Full Text] [Related]
